Healthcare Resource Utilization, Costs, Clinical Events, and Treatment Patterns in Extreme High-Risk Patients for Cardiovascular Events Undergoing Lipoprotein Apheresis: A German…
Carsten Siegert,Ulf Maywald,Uwe Fraass,Thomas Wilke,Nils Picker,Severin Baumann,Rene Oberstedt,Andrea Friederich · Gesundheitsökonomie & Qualitätsmanagement · 2024 · Heft 3 · S. 154 bis 163
Bibliografische Angaben
Zusammenfassung
Abstract Aim Insights into treatment patterns, clinical and economic burden of patients undergoing Lipoprotein apheresis (LA). 3 cohorts were characterized: newly treated [Cohort A], experienced [B], matched cohort [C, high CV risk without LA]. Method Clinical burden was assessed by cardiovascular-related hospitalizations and procedures. Economic and clinical outcomes were described over a 12-month baseline period up to 3 years after LA initiation. Results Absolute LA cases decreased from 1. 7 to 1. 1 per 100, 000 patients. In Cohort A, rate of major cardiovascular hospitalizations decreased, while annual health…
